Trending

ViiV Healthcare

ViiV files monthly HIV jab in Europe

ViiV files monthly HIV jab in Europe

ViiV Healthcare has submitted its once-monthly two-drug injectable therapy for HIV to the EMA, setting up possible approval

X

ViiV files monthly HIV jab in Europe

https://pharmaphorum.com/news/viiv-files-monthly-hiv-jab-in-europe/

ViiV’s first-in-class HIV drug on course for filings this year

ViiV’s first-in-class HIV drug on course for filings this year

ViiV Healthcare has new data on its first-in-class HIV drug fostemsavir that back up its long-term effects, and

X

ViiV’s first-in-class HIV drug on course for filings this year

https://pharmaphorum.com/news/viivs-first-in-class-hiv-drug-on-course-for-filings-this-year/

GSK’s monthly HIV treatment breakthrough

GSK’s monthly HIV treatment breakthrough

GlaxoSmithKline has seen positive clinical results from the phase 3 study of its once-monthly injectable HIV treatment, stepping

X

GSK’s monthly HIV treatment breakthrough

https://pharmaphorum.com/news/gsks-monthly-hiv-treatment-breakthrough/

ViiV prepares another two-drug HIV filing

ViiV prepares another two-drug HIV filing

ViiV Healthcare says it is on course to change standard care in HIV treatment by providing another combination

X

ViiV prepares another two-drug HIV filing

https://pharmaphorum.com/news/viiv-prepares-another-two-drug-hiv-filing/

Positive results announced for ViiV Healthcare’s two-drug HIV pill

Positive results announced for ViiV Healthcare’s two-drug HIV pill

A two-drug strategy has shown positive results, giving new hope to patients with HIV. ViiV Healthcare, which is

X

Positive results announced for ViiV Healthcare’s two-drug HIV pill

https://pharmaphorum.com/news/positive-results-hiv-pill/

ViiV’s HIV drug could be used for TB co-infection patients

ViiV’s HIV drug could be used for TB co-infection patients

Interim results suggest new treatment option for patients with TB and HIV

X

ViiV’s HIV drug could be used for TB co-infection patients

https://pharmaphorum.com/news/viivs-tivicay-used-hiv-patients-tb-study/

ViiV to begin trials of HIV prevention injection

ViiV to begin trials of HIV prevention injection

GSK hopes patients will prefer PrEP injection to pills.

X

ViiV to begin trials of HIV prevention injection

https://pharmaphorum.com/news/viiv-trials-hiv-prevention-injection/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com